ClinicalTrials.gov
ClinicalTrials.gov Menu

FINGER; Finland-Germany Myocardial Infarction Study (FINGER)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00828698
Recruitment Status : Completed
First Posted : January 26, 2009
Last Update Posted : January 26, 2009
Sponsor:
Collaborators:
Medical Council of the Finnish Academy of Science
Finnish Foundation for Cardiovascular Research
Bundesministerium für Bildung, Wissenschaft, Forschung und Technologie
Kommission für Klinische Forschung
German Research Foundation
Information provided by:
University of Oulu

Brief Summary:
The purpose of this observational study is to find characteristics and risk stratification methods for identification of subjects who have increased risk of death, especially sudden cardiac death, after acute myocardial infarction.

Condition or disease Intervention/treatment
Acute Myocardial Infarction Other: No intervention

Study Type : Observational
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Finnish-German Prospective, Observational Follow-up Study on Risk Assessment of Mortality After Myocardial Infarction
Study Start Date : January 1996
Actual Primary Completion Date : January 2000

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Heart Attack
U.S. FDA Resources

Group/Cohort Intervention/treatment
Acute Myocardial Infarction patients Other: No intervention



Primary Outcome Measures :
  1. All cause mortality [ Time Frame: 10years ]

Secondary Outcome Measures :
  1. Sudden cardiac death [ Time Frame: 10 years ]

Biospecimen Retention:   Samples With DNA
DNA samples from Finnish subjects in the study have been retained.


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Consecutive patients who have been hospitalized for acute myocardial infarction from Munich, Germany and Oulu, Finland
Criteria

Inclusion Criteria:

  • Diagnosis of acute myocardial infarction
  • Consent to the study

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00828698


Locations
Finland
Oulu University Hospital
Oulu, Finland, FIN-90014
Germany
Deutsches Herzzentrum
Munich, Germany, D-80636
Sponsors and Collaborators
University of Oulu
Medical Council of the Finnish Academy of Science
Finnish Foundation for Cardiovascular Research
Bundesministerium für Bildung, Wissenschaft, Forschung und Technologie
Kommission für Klinische Forschung
German Research Foundation

Publications of Results:
Responsible Party: Professor Heikki V Huikuri, University of Oulu
ClinicalTrials.gov Identifier: NCT00828698     History of Changes
Other Study ID Numbers: Finger-96
First Posted: January 26, 2009    Key Record Dates
Last Update Posted: January 26, 2009
Last Verified: January 2009

Keywords provided by University of Oulu:
Death, sudden
All cause mortality

Additional relevant MeSH terms:
Infarction
Myocardial Infarction
Ischemia
Pathologic Processes
Necrosis
Myocardial Ischemia
Heart Diseases
Cardiovascular Diseases
Vascular Diseases